Results for tag: "Encephalopathy Drug"

The Encephalopathy Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat diseases and disorders of the brain and spinal cord. Encephalopathy drugs are used to treat a variety of conditions, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and stroke. These drugs are typically administered orally, intravenously, or intramuscularly, depending on the severity of the condition. Commonly used encephalopathy drugs include acetylcholinesterase inhibitors, anticonvulsants, and anti-inflammatory agents. Some of the major companies in the Encephalopathy Drug market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Other companies include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, and Johnson & Johnson. Show Less Read more